Terms: = Kidney tumors AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Clinical Outcome
242 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with clinical outcomes of Guillain-Barre Syndrome Variants.
Bano S; Nawaz A; Nasim A; Numan A; Zahid M
J Coll Physicians Surg Pak; 2024 Feb; 34(2):187-192. PubMed ID: 38342870
[TBL] [Abstract] [Full Text] [Related]
3. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
[TBL] [Abstract] [Full Text] [Related]
4. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
5. [clinical outcome of Surgical Resection for Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus].
Nakanishi H; Ohba K; Nakamura Y; Yasuda T; Mitsunari K; Matsuo T; Mochizuki Y; Miyata Y
Hinyokika Kiyo; 2023 Aug; 69(8):207-214. PubMed ID: 37667597
[TBL] [Abstract] [Full Text] [Related]
6. Better prediction of clinical outcome in clear cell renal cell carcinoma based on a 6 metabolism-related gene signature.
Yu Z; Zhan Y; Guo Y; He D
Sci Rep; 2023 Jul; 13(1):11490. PubMed ID: 37460577
[TBL] [Abstract] [Full Text] [Related]
7. Curative pelvic exenteration: initial experience and clinical outcome.
Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
[TBL] [Abstract] [Full Text] [Related]
8. Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab.
Matsumura S; Kato T; Kujime Y; Kitakaze H; Nakano K; Hongo S; Yoshioka I; Okumi M; Nonomura N; Takada S
BMC Urol; 2023 Jun; 23(1):107. PubMed ID: 37301837
[TBL] [Abstract] [Full Text] [Related]
9. Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.
Behrendt CE; Villalona-Calero MA; Newman EM; Frankel PH
Contemp Clin Trials; 2023 Feb; 125():107083. PubMed ID: 36638911
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of Cyclin F Promotes Cellular Senescence through Cyclin-dependent Kinase 1-mediated Cell Cycle Regulation.
Li X; Li YJ; Wang MJ; Ou KP; Chen YQ
Curr Med Sci; 2023 Apr; 43(2):246-254. PubMed ID: 36602672
[TBL] [Abstract] [Full Text] [Related]
11. Metastatic Thyroid Carcinoma to the kidneys Presenting Initially as Bilateral Renal Masses: A Rare Case Report and Literature Review.
Youssef B; Hanna K; Bowman A; Ardor GD; Alhaj AM; Nassar A
Int J Surg Pathol; 2023 Aug; 31(5):795-800. PubMed ID: 36437643
[TBL] [Abstract] [Full Text] [Related]
12. Cigarette smoking and adverse health outcomes in patients treated with maintenance dialysis.
Bek SG; Marschner S; Sud K; Johnson DW; Chow CK; Hawley C; Pilmore H; Wong G; Lim W; Lee VW
Nephrology (Carlton); 2023 Jan; 28(1):21-27. PubMed ID: 36222366
[TBL] [Abstract] [Full Text] [Related]
13. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract] [Full Text] [Related]
14. Factors affecting prognosis of the patients with severe hyponatremia.
Turkmen E; Karatas A; Altindal M
Nefrologia (Engl Ed); 2022; 42(2):196-202. PubMed ID: 36153916
[TBL] [Abstract] [Full Text] [Related]
15. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
[No Abstract] [Full Text] [Related]
16. Minors at risk of von Hippel-Lindau disease: 10 years' experience of predictive genetic testing and follow-up adherence.
Vibert R; Lahlou-Laforêt K; Samadi M; Krivosic V; Blanc T; Amar L; Burnichon N; Abadie C; Richard S; Gimenez-Roqueplo AP
Eur J Hum Genet; 2022 Oct; 30(10):1171-1177. PubMed ID: 35918537
[TBL] [Abstract] [Full Text] [Related]
17. Liver Transplant for Adult Recurrent Hepatic Mesenchymal Hamartoma and a Feasible Treatment Modality: A Case Report and Literature Review.
Idrees M; Chung K; Philipoff A; Jeffrey G; Garas G; Jaques B; Delriviere L; De Boer B; Bhandari M; Mou L
Transplant Proc; 2022; 54(6):1636-1639. PubMed ID: 35842317
[TBL] [Abstract] [Full Text] [Related]
18. Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study.
Kato T; Fujita K; Minami T; Nagahara A; Hyashi Y; Nakata W; Matsuzaki K; Nakano K; Hatano K; Kawashima A; Imamura R; Takada S; Nishimura K; Tsujihata M; Takao T; Nakai Y; Nakayama M; Nishimura K; Uemura M; Uemura H; Nonomura N
Int J Clin Oncol; 2022 Oct; 27(10):1596-1604. PubMed ID: 35831538
[TBL] [Abstract] [Full Text] [Related]
19. Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study.
Kolar J; Llaurado AF; Ulamec M; Skenderi F; Perez-Montiel D; Alvarado-Cabrero I; Bulimbasic S; Sperga M; Tretiakova M; Osunkoya AO; Rogala J; Comperat E; Gal V; Dunatov A; Pivovarcikova K; Michalova K; Vesela AB; Slisarenko M; Strakova AP; Pitra T; Hora M; Michal M; Alaghehbandan R; Hes O
Ann Diagn Pathol; 2022 Oct; 60():151978. PubMed ID: 35609473
[TBL] [Abstract] [Full Text] [Related]
20. Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial.
Bilen MA; Rini BI; Voss MH; Larkin J; Haanen JBAG; Albiges L; Pagliaro LC; Voog EG; Lam ET; Kislov N; McGregor BA; Lalani AA; Huang B; di Pietro A; Krulewicz S; Robbins PB; Choueiri TK
Clin Cancer Res; 2022 Feb; 28(4):738-747. PubMed ID: 34789480
[TBL] [Abstract] [Full Text] [Related]
[Next]
